Century Pharmaceuticals Ltd

Development, validation and commercialization of therapeutic targeted apoptopic proteins for asthma and allergy is undertaken by Century. It has started its Biotech division by setting up a US FDA approvable laboratory to validate unique targeted therapeutic apoptopic proteins with no side effect in treatment. Future plans include development work on cancer treatment.

Activity:

- Contract Research
- Manufacturing
- Market Research & Marketing
- Research & Development

Product / Technology type(s) covered:

- API / chemicals
- Bio
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Proteins

Therapeutic targets:

- Allergy
- Asthma

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Asia , Central/South America , Europe , Near/Middle East , North America

c. Countries active: United States, Canada, France, Switzerland, Spain, Japan, China, Israel, Pakistan

Corporate data:

Number of Employees: 50

Turnover:

Amount:	Year:	Currency:
4500000	2006	US Dollar

Year founded: 1982

Partners / Alliances: Alliances: Indo-Amercian Chamber of Commerce, Exim Club